The influenza vaccine licensing process

被引：50

作者：

Wood, JM

Levandowski, RA

机构：

[1] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England

[2] Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA

来源：

VACCINE | 2003年 / 21卷 / 16期

关键词：

influenza; vaccines; licensing; pandemic;

D O I：

10.1016/S0264-410X(03)00073-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Influenza vaccines are unique because they require a licensing process which includes a procedure for rapid annual updates to vaccine strains. The licensing procedures in the European Union and the USA are described as examples. In the event of an influenza pandemic, vaccines will be required urgently and licensing process should reflect such needs. Published by Elsevier Science Ltd.

引用

页码：1786 / 1788

页数：3

共 8 条

[1]

*COMM PROP MED PRO, 1997, NOT GUID HARM REQ IN

[2]

*EUR UN, 1995, OFFICIAL J EUROPEAN

[3]

GERDIL C, IN PRESS VACCINE

[4]

LAMONTAGNE JR, 1983, REV INFECT DIS, V5, P723

[5]

PARKMAN PD, 1977, J INFECT DIS, V136, pS722, DOI 10.1093/infdis/136.Supplement_3.S722

[6]

*WHO, 2002, GLOB AG INFL SURV CO

[7]

World Health Organization, 1999, WHOCDSCSREDC991

[8] TRIALS OF INFLUENZA A-NEW-JERSEY-76 VIRUS-VACCINE IN NORMAL CHILDREN - OVERVIEW OF AGE-RELATED ANTIGENICITY AND REACTOGENICITY [J].

WRIGHT, PF ;

THOMPSON, J ;

VAUGHN, WK ;

FOLLAND, DS ;

SELL, SHW ;

KARZON, DT .

JOURNAL OF INFECTIOUS DISEASES, 1977, 136 :S731-S741

← 1 →